Patent ID: 7452538

Claim:
A method for treating cancer comprising administering to an individual therapeutically effective amounts of: (a) a first therapeutic agent comprising an antibody which binds to a polypeptide selected from the group consisting of: (i) amino acids 1 to 468 of SEQ ID NO:2; (ii) amino acids 24 to 468 of SEQ ID NO:2; (iii) amino acids 24 to 238 of SEQ ID NO:2; (iv) the amino acid sequence of the full-length polypeptide encoded by the cDNA contained in ATCC Deposit No. 97853; (v) the amino acid sequence of the mature polypeptide encoded by the cDNA contained in ATCC Deposit No. 97853; and (vi) the amino acid sequence of the extracellular domain of the polypeptide encoded by the cDNA contained in ATCC Deposit No. 97853; and (b) a second therapeutic agent selected from the group consisting of: (i) TRAIL; (ii) a tumor necrosis factor (iii) a chemotherapeutic agent; and (iv) a cytokine.